Sammenfattet var der ingen forskelle med hensyn til bivirkninger forbundet med administration af amlodipin og lisinopril mellem de tre undersøgte behandlinger, og undersøgelsens resultater gav ikke anledning til nogen yderligere sikkerhedsspørgsmål.
In summary, there were no differences with respect to adverse events associated with the administration of amlodipine and lisinopril between the three investigated treatments, and no additional safety issues were raised by the results of the study.